WEDNESDAY, June 5, 2024 (HealthDay News) — A U.S. Food and Drug Administration advisory panel on Tuesday voted against recommending the psychedelic MDMA for the treatment of post-traumatic stress disorder (PTSD). In a 10-1 vote, the panel determined the evidence amassed so far fails to show the controversial drug’s benefitsContinue Reading

WEDNESDAY, June 5, 2024 (HealthDay News) — In new guidelines released Tuesday, U.S. health officials now recommend that certain people take the antibiotic doxycycline as a morning-after pill to lower the risk of some sexually transmitted diseases (STDs). The latest recommendations only apply to gay and bisexual men and transgenderContinue Reading

WEDNESDAY, June 5, 2024 (HealthDay News) — Teens on the verge of falling asleep behind the wheel is a common threat to public safety on U.S. roadways, a new study reports. About 1 in 6 teenage drivers say they’ve driven while drowsy, according to a National Sleep Foundation study presentedContinue Reading

WEDNESDAY, June 5, 2024 (HealthDay News) — A malaria drug could help immune-compromised people who can’t shake off babesiosis, a tick-borne parasitic infection, a new study says. The drug tafenoquine helped cure four New England patients whose babesiosis infections weren’t knocked out by the usual standard of care, researchers reportedContinue Reading

TUESDAY, June 4, 2024 (HealthDay News) — Artificial intelligence (AI) can improve doctors’ assessments of mammograms, accurately detecting even the smallest breast cancers with fewer scary false positive readings, a new study shows. AI-assisted mammography detected significantly more breast cancers, with a lower false-positive rate, than doctors assessing mammograms onContinue Reading